22 October 2024NewsAmericasMarisa Woutersen

10x Genomics counsel: ‘Winning cases is a top priority’

10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

BlueAllele says rival gained $100m from Regeneron deal using patented tech

9 July 2024 Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele.

Americas

Moderna wins reprieve in COVID-19 vaccine dispute

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

More on this story

Biotechnology

BlueAllele says rival gained $100m from Regeneron deal using patented tech

9 July 2024 Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele.

Americas

Moderna wins reprieve in COVID-19 vaccine dispute

More on this story

Biotechnology

BlueAllele says rival gained $100m from Regeneron deal using patented tech

9 July 2024 Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele.

Americas

Moderna wins reprieve in COVID-19 vaccine dispute